Medicxi Ventures Management (Jersey) Ltd Portfolio Stock Holdings

According to the SEC 13F filed on November 2, 2026, Medicxi Ventures Management (Jersey) Ltd disclosed 3 stock positions valued at approximately $126.66M as of quarter-end September 30, 2026. The largest holdings include PHATHOM PHARMACEUTICALS INC, NEWAMSTERDAM PHARMA COMPANY, and AURA BIOSCIENCES INC.

Report Period: September 30, 2026
No. of Stocks: 3
Portfolio Value: $126.66M

Holdings by Sector

Medicxi Ventures Management (Jersey) Ltd Portfolio Holdings in Q3 2026

Company	Symbol	Sector	Portfolio %	Shares	Change (Shares)	Change %	Value
PHATHOM PHARMACEUTICALS INC	PHAT	Healthcare	43.02%	7,464,572	-	-	$54,491,376
NEWAMSTERDAM PHARMA COMPANY	NAMSW	Other	41.90%	2,182,339	-26,300	-1.19%	$53,074,484
AURA BIOSCIENCES INC	AURA	Healthcare	15.07%	3,039,892	-	-	$19,090,522

Showing 3 of 3 holdings in the latest reporting period.